Zentiva and Euractiv Unite Policymakers to Transform EU Health Policy: In a pivotal moment for the future of European healthcare, Zentiva, a leading provider in the off-patent pharmaceutical sector, joined forces with Euractiv to host a high-level Health Policy Conference in Brussels on May 22, 2025. The event brought together top EU policymakers, health experts, and industry leaders to chart a new course for pharmaceutical legislation that champions equitable access to medicine. Steffen Saltofte, CEO of Zentiva, opened the panel discussion by calling for a collective, patient-centered approach to health policy. His message was clear: “Equal access to medicines must become a fundamental right across Europe, supported by sustainable, resilient, and economically viable systems.”
During the panel titled “The EU Pharmaceutical Legislation – Ensuring Fair Access to Medicines for All,” Saltofte underscored the vital importance of unified collaboration between innovators, off-patent manufacturers, regulators, and decision-makers. Highlighting Zentiva’s steadfast service through the COVID-19 pandemic and ongoing medicine shortages, he advocated for a system built on predictability, simplified regulations, and incentives for local EU-based manufacturing. Saltofte emphasized that achieving healthcare sovereignty requires forward-looking policy reform that supports competition, reduces dependency on imports, and maintains continuous, affordable drug supply chains for all citizens.
Moderated by EURACTIV’s Anna Gumbau, the panel featured notable figures such as Rainer Becker from DG SANTE, European Parliament members Stine Bosse and Ondřej Knotek. The discussion delved into aligning industrial, pharmaceutical, and environmental policies, such as mitigating the risks posed by the Urban Wastewater Treatment Directive on pharmaceutical innovation. In addition, the panel stressed the adoption of digital tools, value-added medicine incentives, and fair pricing structures that reflect actual production costs. Platforms like Euractiv’s are instrumental in shaping responsive, inclusive health policies that prioritize patients and support the wider European goal of accessible healthcare for all.
Who Can Apply?
This collaborative initiative is aimed primarily at:
- Policymakers across the EU
- Healthcare providers and professionals
- Pharmaceutical manufacturers and industry stakeholders
- Patient advocacy groups and non-governmental organizations (NGOs)
- Researchers and academic institutions involved in public health policy
Anyone working within or connected to the EU healthcare ecosystem can contribute insights, join upcoming sessions, or engage in policy-driven discussions initiated by Zentiva and Euractiv.
Insurance Fees and Policy Inclusion
There are no specific insurance fees to participate in policy-related initiatives. However, the broader discussion may influence:
- Healthcare insurance providers
- Coverage policies for essential and off-patent medicines
- Incentive schemes for pharmaceutical companies producing generics
This event does not replace personal or institutional insurance policies but aims to shape legislation that could reduce healthcare costs and increase access to insured treatments.
How to Use the Insights and Engage
Stakeholders are encouraged to:
- Follow up with published outcomes from the Euractiv conference
- Subscribe to newsletters from Euractiv and Zentiva
- Join related webinars or forums focusing on EU health policy
- Participate in surveys and consultation rounds on pharmaceutical legislation
These insights help shape national and regional policies, particularly around access, affordability, and innovation in healthcare.
How to Benefit from the Initiative
By aligning with this policy shift, stakeholders can:
- Advocate for a fairer pharmaceutical system
- Support local production and improve drug supply chains
- Influence EU directives that affect healthcare delivery
- Increase awareness of environmental impacts on medicine production
- Champion sustainable and digital healthcare practices
How to Apply for Participation
To take part in future conferences or policy dialogues:
- Visit www.euractiv.com
- Navigate to the “Health” section under “Policy Areas”
- Subscribe to event updates and policy briefings
- Contact organizers via the website for speaking or panel opportunities
Important Dates
- May 22, 2025: Initial conference held in Brussels
- June 2025: Post-conference summary and consultation period opens
- Q3 2025: Additional stakeholder workshops across EU regions
- Q4 2025: Proposed amendments to EU Pharmaceutical Legislation announced
Disclaimer
This article is for informational purposes only and does not constitute legal, professional, or medical advice. Readers should consult official sources or healthcare professionals before making decisions based on the policy discussions described herein.
Zentiva and Euractiv Unite Policymakers to Transform EU Health Policy Conclusion
Zentiva and Euractiv’s joint effort in organizing the Health Policy Conference marks a significant milestone in reshaping the EU’s pharmaceutical landscape. By uniting policymakers, industry leaders, and patient advocates, the initiative seeks to establish a more resilient, inclusive, and accessible healthcare system. The emphasis on sustainable practices, local manufacturing, and digital innovation points toward a future where healthcare is not only a right but also a readily available service for every European.
Events like this serve as catalysts for long-term change. They provide platforms for honest dialogue, mutual understanding, and shared goals among all stakeholders. As healthcare systems face increasing pressure from demographic shifts, pandemics, and climate change, building a foundation based on collaboration and foresight becomes critical.
This conference highlights how proactive policy, stakeholder cooperation, and a people-first mindset can shape a healthier Europe. The call for unified efforts, predictable frameworks, and smart regulations resonates with ongoing efforts to ensure medicines are available when and where they’re needed the most.
In conclusion, Zentiva’s leadership, together with Euractiv’s convening power, is playing a key role in promoting policies that are not only economically viable but also ethically grounded. Their vision of “One Healthcare, For All” could very well become the blueprint for the EU’s future in pharmaceutical governance.
Zentiva and Euractiv Unite Policymakers to Transform EU Health Policy FAQs
1. What is the goal of the Zentiva and Euractiv Health Policy Conference?
The conference aims to bring together key stakeholders to discuss reforms in the EU’s pharmaceutical legislation that promote equitable access, sustainable healthcare practices, and resilient medicine supply chains.
2. How does this initiative affect the average EU citizen?
By advocating for fair competition, local manufacturing, and sustainable pricing, the policy reforms discussed could lead to more affordable and accessible medicines across Europe.
3. Are there any costs associated with participating in the conference?
No, participation in policy discussions or attending forums like Euractiv’s Health Policy Conference generally comes at no cost, although registration is often required.
4. Can individuals from outside the EU participate?
While the policy focus is on the EU, international experts, academics, and stakeholders with interests in European healthcare policy are often welcome to observe or contribute, depending on the event’s scope.
5. Where can I find updates about future health policy events?
Regular updates are available on the Euractiv website’s health section and through Zentiva’s official communications and press releases.
